• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine.

作者信息

Shostak Yael, Shafran Noa, Heching Moshe, Rosengarten Dror, Shtraichman Osnat, Shitenberg Dorit, Amor Shai M, Yahav Dafna, Ben Zvi Haim, Pertzov Barak, Kramer Mordechai R

机构信息

Department of Medicine D, Rabin Medical Center, Petach Tikva, Israel; Pulmonary Division, Rabin Medical Center, Petach Tikva 49100, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Department of Medicine D, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Lancet Respir Med. 2021 Jun;9(6):e52-e53. doi: 10.1016/S2213-2600(21)00184-3. Epub 2021 May 5.

DOI:10.1016/S2213-2600(21)00184-3
PMID:33964244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8099313/
Abstract
摘要

相似文献

1
Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine.接种BNT162b2疫苗的肺移植受者的早期体液反应。
Lancet Respir Med. 2021 Jun;9(6):e52-e53. doi: 10.1016/S2213-2600(21)00184-3. Epub 2021 May 5.
2
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine.COVID-19 疫苗在肺和肝移植受者中的效果超出预期：BNT162b2 疫苗的免疫原性和临床疗效的意大利真实世界经验。
Transpl Int. 2024 Jul 10;37:12729. doi: 10.3389/ti.2024.12729. eCollection 2024.
3
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.肾移植受者接种 3 剂 BNT162b2 mRNA SARS-CoV-2 疫苗后的细胞和体液免疫反应
Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.
4
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.心脏和胸部移植受者对两剂 SARS-CoV-2 信使 RNA 疫苗 BNT162b2 的体液和 T 细胞应答较差。
Clin Res Cardiol. 2021 Aug;110(8):1142-1149. doi: 10.1007/s00392-021-01880-5. Epub 2021 Jul 9.
5
The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines.加强针接种间隔时间对 BNT162b2 疫苗接种的实体器官移植受者体液免疫应答的影响。
Viruses. 2024 May 28;16(6):860. doi: 10.3390/v16060860.
6
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients.青少年和年轻成年肾移植受者对 BNT162b2 COVID-19 mRNA 疫苗的血清学反应。
Transplantation. 2021 Nov 1;105(11):e226-e233. doi: 10.1097/TP.0000000000003922.
7
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.移植前接种疫苗的肾移植受者对 SARS-CoV-2 疫苗保持优越的体液反应。
Clin Transplant. 2021 Dec;35(12):e14478. doi: 10.1111/ctr.14478. Epub 2021 Sep 29.
8
Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.肾移植受者对 SARS-CoV-2 mRNA 疫苗的抗体反应：一项前瞻性队列研究。
Clin Microbiol Infect. 2021 Aug;27(8):1173.e1-1173.e4. doi: 10.1016/j.cmi.2021.04.028. Epub 2021 May 3.
9
COVID-19 After Vaccination in Lung Transplant Recipients: Real-Life Data.肺移植受者接种疫苗后感染新冠病毒：真实数据
Exp Clin Transplant. 2023 Mar;21(3):265-271. doi: 10.6002/ect.2022.0088. Epub 2022 Jul 22.
10
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列卫生保健工作者中，第三剂 BNT162b2 疫苗接种与 SARS-CoV-2 感染发生率的关联。
JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641.

引用本文的文献

1
Respiratory viral infections in lung transplantation: Recent advances in epidemiology, clinical impact, and therapeutic approaches.肺移植中的呼吸道病毒感染：流行病学、临床影响及治疗方法的最新进展
JHLT Open. 2025 Aug 5;10:100362. doi: 10.1016/j.jhlto.2025.100362. eCollection 2025 Nov.
2
Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirement.免疫功能低下的严重 COVID-19 且高氧需求患者的免疫调节治疗的临床结局。
Sci Rep. 2024 Jul 23;14(1):16985. doi: 10.1038/s41598-024-68013-6.
3
Risk of severe COVID in solid organ transplant recipient.实体器官移植受者发生严重 COVID 的风险。
Rev Esp Quimioter. 2023 Nov;36 Suppl 1(Suppl 1):15-17. doi: 10.37201/req/s01.04.2023. Epub 2023 Nov 24.
4
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients.实体器官移植成年候选者及受者的疫苗接种建议
Vaccines (Basel). 2023 Oct 18;11(10):1611. doi: 10.3390/vaccines11101611.
5
Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients-A Prospective Longitudinal Study.实体器官移植受者中2019冠状病毒病疫苗接种的抗体反应延迟且减弱，交叉变异中和能力差——一项前瞻性纵向研究
Open Forum Infect Dis. 2023 Aug 10;10(8):ofad369. doi: 10.1093/ofid/ofad369. eCollection 2023 Aug.
6
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.实体器官移植受者对 SARS-CoV-2 感染的易感性和对 COVID-19 疫苗接种的免疫反应。
J Infect Dis. 2023 Aug 4;228(Suppl 1):S34-S45. doi: 10.1093/infdis/jiad152.
7
Humoral and Cellular Immunity following Five Doses of COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.实体器官移植受者接种五剂新冠疫苗后的体液免疫和细胞免疫：一项系统评价和荟萃分析
Vaccines (Basel). 2023 Jun 27;11(7):1166. doi: 10.3390/vaccines11071166.
8
Increasing Antibody Responses to Five Doses of SARS-CoV-2 mRNA Vaccine in Lung Transplant Patients.肺移植患者对五剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗的抗体反应增强
J Clin Med. 2023 Jun 18;12(12):4125. doi: 10.3390/jcm12124125.
9
Predominantly defective CD8 T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients.肺移植受者对 SARS-CoV-2 mRNA 疫苗接种的主要缺陷性 CD8 T 细胞免疫。
J Transl Med. 2023 Jun 8;21(1):374. doi: 10.1186/s12967-023-04234-z.
10
Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.器官移植受者接种2019冠状病毒病疫苗后的免疫原性、安全性及严重急性呼吸综合征冠状病毒2突破性感染：一项加拿大前瞻性多中心研究
Open Forum Infect Dis. 2023 Apr 13;10(5):ofad200. doi: 10.1093/ofid/ofad200. eCollection 2023 May.

本文引用的文献

1
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.mRNA 疫苗在实体器官移植受者中的单剂免疫原性。
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
2
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
3
Immunosuppression for Lung Transplantation: Current and Future.肺移植的免疫抑制：现状与未来
Curr Transplant Rep. 2018 Sep;5(3):212-219. doi: 10.1007/s40472-018-0199-4. Epub 2018 Jul 13.
4
Serologic vaccination response after solid organ transplantation: a systematic review.实体器官移植后的血清疫苗反应：系统评价。
PLoS One. 2013;8(2):e56974. doi: 10.1371/journal.pone.0056974. Epub 2013 Feb 22.
5
Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients.随机对照试验：高剂量皮内与标准剂量肌内流感疫苗在器官移植受者中的应用。
Am J Transplant. 2013 Apr;13(4):1026-1033. doi: 10.1111/ajt.12149. Epub 2013 Feb 13.